Found: 14
Select item for more details and to access through your institution.
Minimal residual disease monitoring cannot fully replace bone marrow morphology in assessing disease status in pediatric acute lymphoblastic leukemia.
- Published in:
- APMIS, 2020, v. 128, n. 5, p. 414, doi. 10.1111/apm.13037
- By:
- Publication type:
- Article
Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort.
- Published in:
- APMIS, 2015, v. 123, n. 8, p. 652, doi. 10.1111/apm.12411
- By:
- Publication type:
- Article
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab‐containing line of therapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E117, doi. 10.1002/ajh.26449
- By:
- Publication type:
- Article
The real-world outcomes of multiple myeloma patients treated with daratumumab.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258487
- By:
- Publication type:
- Article
Human cancer evolution in the context of a human immune system in mice.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 10, p. 1797, doi. 10.1002/1878-0261.12374
- By:
- Publication type:
- Article
Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Addressing the room for improvement in management of acute promyelocytic leukemia.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 6, p. 479, doi. 10.1111/ejh.13229
- By:
- Publication type:
- Article
Myc protein overexpression is a feature of progression and adverse prognosis in multiple myeloma.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 585, doi. 10.1111/ejh.13141
- By:
- Publication type:
- Article
Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 1, p. 46, doi. 10.1111/ejh.12546
- By:
- Publication type:
- Article
Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 3, p. 211, doi. 10.1111/ejh.12473
- By:
- Publication type:
- Article
NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression.
- Published in:
- European Journal of Haematology, 2011, v. 87, n. 5, p. 400, doi. 10.1111/j.1600-0609.2011.01673.x
- By:
- Publication type:
- Article
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 521, doi. 10.1002/hon.2906
- By:
- Publication type:
- Article
Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E611, doi. 10.1002/ajh.24857
- By:
- Publication type:
- Article
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188988
- By:
- Publication type:
- Article